IMUNON Unveils Exciting Phase 1-2 OVATION 2 Study Results: IMNN-001’s Progress Against Advanced Ovarian Cancer

Delving Deeper into the World of IMNN-001: Unraveling the Dose-Dependent Mechanism In the ever-evolving landscape of pharmaceutical research, a recent study has shed new light on the dose-dependent effects of IMNN-001, a promising therapeutic agent. This intriguing finding reveals that the 100mg/m2 dose is associated with a 20% increase in IL-12 levels compared to the…

Read More

Unlocking the Potential: Gold Price Holds Steady Below $2,500, Bullish Outlook Remains Strong

Gold Price Plummets Below $2,500 After Mixed US Jobs Report Intraday Turnaround The gold price (XAU/USD) witnessed an intraday turnaround from the vicinity of the all-time peak and dropped back below the $2,500 psychological mark following the release of the key US monthly employment details on Friday. The mixed US jobs report reduced the likelihood…

Read More

Hycroft Files 2024-10K Report and Provides Corporate Update: A Comprehensive Look

Hycroft Mining Holding Corporation Reports 2024 Full-Year Results and Files Form 10-K Winnemucca, NV, March 5, 2025 – Hycroft Mining Holding Corporation (Nasdaq: HYMC) (“Hycroft” or the “Company”), a leading precious metals and copper mining company, is pleased to announce the release of its 2024 full-year financial results and the filing of its Annual Report…

Read More

Breaking the Mold: Why Cypriot Companies Shy Away from Freelancers and Contractors

Around the world, businesses of every sort, size and shape are using freelance specialists Why Cypriot companies shy away from hiring freelancers Cypriot firms seem resistant to working with freelancers or contractors Freelancers have become an integral part of many businesses globally, providing specialized services ranging from design, content creation, video editing, advising, marketing, and…

Read More

Uncovering the Surprising Impact of Trump’s DJT Connection on a Lesser-Known Crypto Stock: A 3x Surge in Just One Month!

Cryptocurrency Company’s Shares Soar on Trump Acquisition Rumors What Happened Bakkt Holdings (NYSE:BKKT) recently experienced a significant surge in its stock price following reports of a potential acquisition by President-elect Donald Trump’s Trump Media & Technology Group (NASDAQ:DJT). The company’s shares nearly tripled in just one month, closing at an 11-month high of $32.44, representing…

Read More

“Reflecting on Success: Atossa Therapeutics’ 2024 Achievements and Exciting Outlook for 2025 – A Letter to Our Valued Shareholders”

Welcome to our Blog Post Atossa Therapeutics Provides Update on Clinical Programs SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company focused on the prevention and treatment of breast cancer. Today, the company’s Chairman and CEO, Steven Quay, M.D., Ph.D., issued a…

Read More

BlackRock TCP Capital Corporation Reports 2024 Financial Results: Net Investment Income of $0.40 per Share, Declares Quarterly Dividend of $0.25 and Special Dividend of $0.04

BlackRock TCP Capital Corp. Reports Fourth Quarter and Full Year 2024 Financial Results SANTA MONICA, Calif. – BlackRock TCP Capital Corp. (TCPC or the Company), a business development company, recently announced its financial results for the fourth quarter and full year ended December 31, 2024. The Company, which is publicly traded on NASDAQ under the…

Read More